| Name | Title | Contact Details |
|---|
The Medical College of Wisconsin, or simply MCW, is a private, freestanding medical school and graduate school of sciences located in Milwaukee, Wisconsin. It was formerly affiliated with Marquette University, but has operated as an independent institution since 1967.[1] MCW is accredited by the Higher Learning Commission of the North Central Association (NCA) of Colleges and Schools and by the Liaison Committee on Medical Education (LCME). The NCA is the accrediting body for all institutions of higher education in the College's geographic region and the LCME is the accrediting body of all US medical schools. Along with the University of Wisconsin School of Medicine and Public Health, it is one of only two medical schools in Wisconsin, and it is the only private medical school in the state.
As the fourth largest entirely student-run businesses generating $1.2 million annually, our mission is to create a competitive advantage for our employees by providing experiential education through the operation of profitable, ethically-focused business that serves the needs for our stakeholders. Founded in 1990, Flyer Enterprises has grown into ten separate divisions, all experiencing stellar and steady growth. From sales associates to the chief executive officer, Flyer Enterprises is comprised of nearly 190 undergraduate student employees. We pride ourselves in giving each of our employees unparalleled, hands-on learning opportunities so that we can take our experiences and learned skills with us after graduation and into Corporate America.
Presidio School of Management is a San Francisco, CA-based company in the Education sector.
Hudson Institute is a Washington, DC-based company in the Education sector.
HistoSonics Inc. is a new medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue excision technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia (BPH), a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.